Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200928048867N1

Enrollment

Registered

2020-10-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute liver failure. Fibrosis and cirrhosis of liver

Interventions

Intervention group: Patients with acute liver failure requiring urgent liver transplant.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Recipients with acute liver failue and MELD score> 20 requiring urgent liver transplant Recipients should have Negetive PCR test/ NO COVID-19 signs and symptoms/ NO lung involvement in HRCT Deceased donors with positive PCR tests or COVID-19 lung involvement in HRCT

Exclusion criteria

Exclusion criteria: Recipients with clinical presentation of COVID-19 OR positive PCR test OR lung involvement in HRCT Deceased donors due to respiratory failure

Design outcomes

Primary

Measure	Time frame
Description of early outcomes of liver transplant from COVID-19 positive deceased donors. Timepoint: 30 days within operation. Method of measurement: Clinical assessments/ liver functional tests.;Evaluation of transmission of COVID-19. Timepoint: 24 hours, day 7 and 14 postoperatively. Method of measurement: Clinical manifestations, PCR test, lung HRCT.	—

Secondary

Measure	Time frame
Long term outcomes of liver transplant from COVID-19 positive deceased donors. Timepoint: 6 months and 1 year postoperatively. Method of measurement: Clinical follow ups and liver function tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Saeidi Shahri

Mashhad University of Medical Sciences

saeidis971@mums.ac.ir+98 51 3845 8671

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026